Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow

Clinical trial NCT00172068 · TERMINATED

Trial details

NCT number: NCT00172068
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Breast Cancer

Start date: 2002-01-01
Primary completion: 2008-11-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.